|
|
||||||||








* Abramson Family Cancer Research Institute, University of Pennsylvania Cancer Center,
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, and
Division of Rheumatology, Childrens Hospital of Philadelphia, Philadelphia, PA 19104; and
Virginia Mason Research Institute, Seattle, WA 98101
To characterize the replicative capacity of human central memory (TCM) CD4 T cells, we have developed a defined culture system optimized for the ex vivo expansion of Ag-specific CD4+ T cells. Artificial APCs (aAPCs) consisting of magnetic beads coated with Abs to HLA class II and a costimulatory Ab to CD28 were prepared; peptide-charged HLA class II tetramers were then loaded on the beads to provide Ag specificity. Influenza-specific DR*0401 CD4 TCM were isolated from the peripheral blood of normal donors by flow cytometry. Peptide-loaded aAPC were not sufficient to induce resting CD4 TCM to proliferate. In contrast, we found that the beads efficiently promoted the growth of previously activated CD4 TCM cells, yielding cultures with >80% Ag-specific CD4 cells after two stimulations. Further stimulation with peptide-loaded aAPC increased purity to >99% Ag-specific T cells. After in vitro culture for 312 wk, the flu-specific CD4 TCM had surface markers that were generally consistent with an effector phenotype described for CD8 T cells, except for the maintenance of CD28 expression. The TCM were capable of 2040 mean population doublings in vitro, and the expanded cells produced IFN-
, IL-2, and TNF-
in response to Ag, and a subset of cells also secreted IL-4 with PMA/ionomycin treatment. In conclusion, aAPCs expand TCM that have extensive replicative capacity, and have potential applications in adoptive immunotherapy as well as for studying the biology of human MHC class II-restricted T cells.
This article has been cited by other articles:
![]() |
S. Caserta, P. Alessi, J. Guarnerio, V. Basso, and A. Mondino Synthetic CD4+ T Cell-Targeted Antigen-Presenting Cells Elicit Protective Antitumor Responses Cancer Res., April 15, 2008; 68(8): 3010 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Migliaccio, P. M. S. Alves, P. Romero, and N. Rufer Distinct Mechanisms Control Human Naive and Antigen-Experienced CD8+ T Lymphocyte Proliferation J. Immunol., February 15, 2006; 176(4): 2173 - 2182. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |